Dietary phosphorus study for moderate kidney disease
Part of Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at how eating different amounts of phosphorus affects your bones and blood calcium and phosphorus. It may help find better dietary recommendations for people with moderate chronic kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 75 years old.
- You have moderate chronic kidney disease (stage 3b or 4), with a specific range of estimated glomerular filtration rate (eGFR) and urine protein levels.
- Your blood parathyroid hormone (PTH) level is above the normal range.
- If you are female, you are postmenopausal, surgically sterile, or have a negative pregnancy test.
- You are willing to stop taking vitamin D, calcium, multivitamins, or other supplements during the study.
- You must have adequate vitamin D status (a blood level of 25-hydroxyvitamin D above 20 ng/mL).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways to record what you eat and drink for people with advanced kidney disease. It may help find easier methods for dietary tracking.
This study looks at how replacing high-protein foods affects people with chronic kidney disease. If you join, you will eat a carefully controlled diet to help researchers understand if changing your protein intake can improve your kidney health.
This study looks at how the body handles phosphate in people with chronic kidney disease. It may help researchers understand how to better manage phosphate levels to improve health.
This trial tests whether regulating parathyroid hormone (PTH) can improve bone density in people with advanced chronic kidney disease (CKD) who are not on dialysis. It may help you if you have stage 4-5 CKD and high PTH levels.
This study looks at how your body handles extra phosphate (a mineral found in many foods) and whether age or sex changes that response. Researchers will give healthy volunteers more phosphate and measure blood and urine levels to understand the effect.
This study tests whether a new medicine called TS-172 can help lower phosphorus levels in patients on peritoneal dialysis (a type of kidney treatment). High phosphorus can cause bone problems and other complications, so the trial aims to see if this drug works better than current treatments.
Hear when a new CKD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.